Your greatest defense is within you. Immunocine was founded to bring revolutionary immunotherapy to cancer patients who are not eligible for FDA clinical trials. Our proprietary treatment, Immunocine Dendritic Cell Therapy (IDCT), “double loads” a patient’s dendritic cells with their own cancer cells. This process mimics a viral infection and triggers a powerful, targeted immune response. Backed by 16 years of research and ongoing FDA trials, IDCT offers a less invasive, highly precise option for treating multiple types of cancer. Visit our website to see if you’re eligible to apply for treatment.
Shared 2 weeks ago
129K views
Shared 1 month ago
432 views
Shared 1 month ago
166 views
Shared 5 months ago
503 views
Shared 6 months ago
364 views
Shared 7 months ago
1.3K views
Shared 8 months ago
389 views
Shared 10 months ago
1.8K views
Shared 11 months ago
8.5K views
Shared 1 year ago
687 views
Shared 1 year ago
808 views
Shared 1 year ago
1.2K views
Shared 1 year ago
1.3K views
Shared 1 year ago
1.4K views
Shared 1 year ago
4.2K views
Shared 1 year ago
3K views
Shared 1 year ago
874 views
Shared 1 year ago
1.8K views
Shared 1 year ago
393 views
Shared 1 year ago
436 views
Shared 1 year ago
743 views
Shared 2 years ago
7.4K views
Shared 2 years ago
3.7K views
Shared 2 years ago
1.1K views
Shared 2 years ago
54K views
Shared 2 years ago
3.6K views
Shared 2 years ago
2.6K views
Shared 3 years ago
1.8K views
Shared 3 years ago
4.3K views
Shared 3 years ago
631 views
Shared 3 years ago
912 views
Shared 3 years ago
2.4K views